Adis Journals and Newsletters - Springerstatic.springer.com/sgw/documents/1359145/... · Adis Journals and Newsletters adis.com The premier collection of drug focused medical journals

Learn more

Adis Journals and Newsletters

adis.com

The premier collection of drug focused medical journals – with expanded content for 2014

2

adis.comAdis Journals

Clinical Pharmacology

Title Impact Factor Description

Added in 2014 Advances in Therapy

2.125 • Dedicated to rapid publication of studies in clinical medicine

• Reviews and original research across a broad range of therapeutic areas

• Evaluation of existing and new drug therapies, diagnostics, instrumentation, and related fields

• Enhanced features such as summary slides and animations reinforce reader understanding

Clinical Drug Investigation

1.915 • A journal focused on clinical investigations of drugs and drug devices

• Efficacy and safety data from a wide range of clinical trials

• Outcomes research and pharmacoeconomics studies included

Clinical Pharmacokinetics

6.109 • Making sense of pharmacokinetic, pharmacodynamic, and pharmacogenetic data

• Emphasis on clinical data in special populations including those with hepatic or renal impairment, women, children, and the elderly

• Evidence-based authoritative reviews on new drugs and drug classes

CNS Drugs

4.826 • Drug developments in both neurology and psychiatry

• Seminal reviews summarizing wide-ranging and complex original research findings

• Succinct guidance on the place of new drugs in clinical practice

• Publishes important original research

Drugs

4.633 • Setting the standards in reviews of all aspects of clinical pharmacology since 1971

• Definitive reviews of drugs and drug classes, and their place in disease management including systematic reviews and meta-analyses

• Pivotal original research

Drugs & Aging

2.646 • Focused on clinical management of diseases with particular relevance to older adults

• Comprehensive reviews and original research promoting optimum drug prescribing and utilization in older patients

• Clinical implications of age-related physiological changes for drug therapy

Drugs & Therapy Perspectives

N/A • Authoritative yet easy-to-read review articles to aid drug formulary and prescribing decisions

• New developments and international consensus on drug therapy • Guidance on management of adverse drug reactions and

interactions • Pharmacoeconomics and outcomes research that impacts on clinical

practice

3

adis.com Adis Journals

Added in 2014 European Journal of Drug Metabolism and Pharmacokinetics

0.944 • Comprehensive journal covering all aspects of pharmacokinetics including drug interactions, bioavailability, and biopharmacy

• Original research and review articles on special topics

• Conference proceedings

Pediatic Drugs

1.884 • Clinical issues affecting drug therapy in children and adolescents

• Efficacy and safety of drugs at all stages of pediatric development

• Addresses optimal formulations and drug delivery in children

• Includes issues surrounding drug access, pharmacogenomics, and costs

Pharmaceutical Medicine

N/A SCImago Cites per Doc. (2y) 0.821*

• Disseminates the latest information on the optimal conduct of clinical studies

• Contributions from top industry physicians, regulators and academics

• Topics include regulatory science, pharmacovigilance, ethics, pharmacology and trial design

Health Economics and Outcomes Research

Title Impact Factor Description

Applied Health Economics and Health Policy

N/A SCImago Cites per Doc. (2yr) 1.894*

• Guide to efficient resource allocation and decision making

• Economic assessment of various healthcare interventions, systems, and policies

• Range of perspectives, from individual institutions to whole countries

Pharmaco-Economics

2.861 • Original research on the cost-effectiveness of drug therapy

• Authoritative reviews on issues related to scarce allocation of resources and formulary management

• Allows decision makers to critically evaluate and comprehend complex pharmacoeconomic reports

Pharmaco-Economics & Outcomes News

N/A • Concise summaries on the latest issues in health economics and outcomes news

• Economic impact of drugs, diseases, devices, diagnostics, and screening protocols; prescribing and drug utilisation trends; quality-of-life effects of drugs; reimbursement decisions; and health policy and reforms

The Patient: Patient-Centered Outcomes Research

1.565 • Ground-breaking journal published in association with Johns Hopkins University

• Illuminates what patients value in their treatment, and what drives adherence

• Provides the latest research on patient-reported outcomes

• Covers risk communication, shared decision making, and health literacy

4

Adis Journalsadis.com

Pharmacovigilance

Title Impact Factor Description

Drug Safety

3.408 • Reviews by leading physicians and academics on benefit-risk assessment, risk management, medication error prevention, and pharmacoepidemiology

• Specific information on drug use in at-risk patient groups, editorials and commentaries on topical issues, and original research

Reactions Weekly

N/A • A weekly round-up of adverse drug reaction news including pharmacovigilance, regulatory, research, and current opinion

• Published adverse event case reports, labelling changes, drug withdrawals, and drug safety research

• First published, drug overdose, drug interaction, and serious case reports highlighted for easy reference

Specialized Therapy Areas

Title Impact Factor Description

American Journal of Cardiovascular Drugs

2.069 • Strong focus on clinical management of cardiovascular disorders

• Evidence-based evaluation of novel drugs and new targets

• Original clinical and pharmacoeconomic research useful for administrators and decision makers

American Journal of Clinical Dermatology

1.844 • Content selected to promote evidence-based therapy and effective patient management in clinical dermatology

• Definitive reviews on management of dermatological conditions

• Clinically relevant original research articles

High Blood Pressure & Cardiovascular Prevention

N/A SCImago Cites per Doc. (2y) 0.658*

• Expert commentary on guidelines and clinical trials

• Time-saving reviews on research into cardiovascular disease prevention

• Insights into socioeconomic issues surrounding cardiovascular disease

• Proceedings of scientific meetings

Targeted Oncology

2.764 • A journal for all healthcare professionals in the field of oncology

• Reviews of new treatments including monoclonal antibodies and small molecules

• Insights into the clinical implications of research into new targets for cancer therapy

Added in 2014

*The SCImago Cites per Doc. (2y) measures the scientific impact of a journal using the same formula as the Impact Factor but using the Scopus database http://www.scimagojr.com

5

adis.comAdis Journals

Biotechnology and Personalized Medicine

Title Impact Factor Description

BioDrugs 2.809 • Independent, definitive reviews on the place of new biologics in clinical practice

• Stem cell therapies

• Emerging treatment strategies and comparative effectiveness

Molecular Diagnosis & Therapy

1.692 • A journal devoted to the field of personalized medicine

• Simplifies complex research on biomarkers, pharmacogenomics, and molecular diagnostics

• Evaluations of drug / diagnostic combinations

• Genetic factors affecting response to drug therapy

Adis Open Access Journals

Open Access Journals New to the Adis Portfolio in 2014: A unique portfolio of internationally peer-reviewed journals dedicated to rapid publication of preclinical, clinical and real-world research in clinical medicine, including research on existing drugs, drugs in development, and devices, across a range of therapeutic areas.

The Rapid+ journals publish original research, reviews, case reports, and short communications, and are of interest to a wide range of pharmaceutical and healthcare professionals.

All articles are published with a summary slide for a visual overview of the key data. Slide decks, animations, videos, and interactive learning resources are also included for some articles to aid interpretation.

Title Description

Drugs in R&D Clinical and preclinical research and reviews of approved and developmental drugs across all therapeutic areas

• Biologics in Therapy

• Cardiology and Therapy

• Dermatology and Therapy

• Diabetes Therapy

• Infectious Diseases and Therapy

• Neurology and Therapy

• Ophthalmology and Therapy

• Pain and Therapy

• Rare Cancers and Therapy

• Rheumatology and Therapy

A01002R | CORR 77-A | Images: page 1: Roman Ponomarets/iStockphotos | page5: PTter Gudella/iStockphotos | page 6: gualtiero boffi/Fotolia

adis.comAdis Journals

Adis Journals and Newsletters An invaluable resource for all involved in medical research, practice or teaching; drug regulation or reimbursement; or the pharmaceutical industry

Adis Publishing Heritage

• Independent and reputable publishers of high quality medical journals for over 40 years

• Unique content from in-house, specially trained Drug Evaluation team

• Commissioned review articles summarize complex and broad topics for your end-users

• Cutting-edge original research in all therapy areas

Expanded Content

• Existing portfolio now publishing approximately 15% more content annually PLUS

• An additional 13 established titles added to the portfolio in 2014

Available on Springer’s Leading Research Platforms

All Adis journal and newsletter content is available on SpringerLink , Springer for R&D, and Springer for Hospitals & Health. These robust, mobile-optimized platforms enable your end users to access over 8 million research documents anytime, anywhere, including thousands of eBooks and more than 400 journals relevant to medical research.

Adis Online Journal Archive • Archive content from 13 high quality Adis Journals and Newsletters, spanning

the years 1971 to 1996

• Content available on the same Springer platforms

• Complete, perpetual access for your readers

Would you like to know more? Contact Springer today.Visit springer.com/salescontacts to find your local Springer representative!

Contact us !

Would you like to know more? Contact Springer today.Visit springer.com/salescontacts to find your local Springer representative!

Contact us !